India allows emergency use of Merck's COVID-19 pill, two more vaccines

An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May

India gave emergency use authorisation (EUA) for Merck's (MRK.N) COVID-19 pill molnupiravir, and Serum Institute of India's Covovax and Biological E's Corbevax coronavirus vaccines, the country's health minister said on Twitter.

Source: Reuters / Reporting by Chandini Monnappa in Bengaluru; Editing by Shounak Dasgupta